Tenecteplase: single-bolus thrombolytic therapy for acute myocardial infarction.
McGahan
L
L
Canadian Coordinating Office for Health Technology Assessment.
D002170:Canada; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000191:economics; D013673:Technology Assessment, Biomedical; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator